This National Cancer Institute (NCI) grant is for research projects focusing on the integration of imaging and fluid-based tumor monitoring, also known as liquid biopsy, during cancer therapy. The primary purpose is to identify the most effective ways to utilize these combined modalities in patients. Specifically, funded projects should aim to better characterize how patients respond to cancer treatments and detect the early emergence of drug resistance. By integrating these advanced monitoring techniques, the NCI seeks to optimize patient care and improve therapeutic outcomes by providing a clearer picture of tumor behavior throughout the treatment journey. This initiative supports innovative approaches to enhance real-time assessment of therapy efficacy.
Opportunity ID: 334872
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | PAR-21-290 |
| Funding Opportunity Title: | Integration of Imaging and Fluid-Based Tumor Monitoring in Cancer Therapy (R01 Clinical Trial Optional) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Education Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.393 — Cancer Cause and Prevention Research |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 2 |
| Posted Date: | Jul 23, 2021 |
| Last Updated Date: | Oct 02, 2024 |
| Original Closing Date for Applications: | Sep 07, 2024 |
| Current Closing Date for Applications: | Jan 07, 2025 |
| Archive Date: | Feb 06, 2025 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | $500,000 |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Native American tribal organizations (other than Federally recognized tribal governments) County governments Public housing authorities/Indian housing authorities Public and State controlled institutions of higher education Native American tribal governments (Federally recognized) Private institutions of higher education State governments Small businesses City or township governments Special district governments Independent school districts Others (see text field entitled “Additional Information on Eligibility” for clarification) Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education For profit organizations other than small businesses Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: |
Through this funding opportunity announcement (FOA), the National Cancer Institute (NCI) seeks research project (R01) grant applications describing projects that integrate imaging and fluid-based tumor monitoring (liquid biopsy) assays during cancer therapy in patients to determine the optimal use of those modalities in the characterization of therapy response and/or emergence of resistance. |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/pa-files/PAR-21-290.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
grantsinfo@nih.gov Email:grantsinfo@nih.gov |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
| updated close date | Oct 02, 2024 | |
| Jul 23, 2021 |
DISPLAYING: Synopsis 2
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | PAR-21-290 |
| Funding Opportunity Title: | Integration of Imaging and Fluid-Based Tumor Monitoring in Cancer Therapy (R01 Clinical Trial Optional) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Education Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.393 — Cancer Cause and Prevention Research |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 2 |
| Posted Date: | Jul 23, 2021 |
| Last Updated Date: | Oct 02, 2024 |
| Original Closing Date for Applications: | Sep 07, 2024 |
| Current Closing Date for Applications: | Jan 07, 2025 |
| Archive Date: | Feb 06, 2025 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | $500,000 |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Native American tribal organizations (other than Federally recognized tribal governments) County governments Public housing authorities/Indian housing authorities Public and State controlled institutions of higher education Native American tribal governments (Federally recognized) Private institutions of higher education State governments Small businesses City or township governments Special district governments Independent school districts Others (see text field entitled “Additional Information on Eligibility” for clarification) Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education For profit organizations other than small businesses Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: |
Through this funding opportunity announcement (FOA), the National Cancer Institute (NCI) seeks research project (R01) grant applications describing projects that integrate imaging and fluid-based tumor monitoring (liquid biopsy) assays during cancer therapy in patients to determine the optimal use of those modalities in the characterization of therapy response and/or emergence of resistance. |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/pa-files/PAR-21-290.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
grantsinfo@nih.gov Email:grantsinfo@nih.gov |
DISPLAYING: Synopsis 1
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | PAR-21-290 |
| Funding Opportunity Title: | Integration of Imaging and Fluid-Based Tumor Monitoring in Cancer Therapy (R01 Clinical Trial Optional) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Education Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.393 — Cancer Cause and Prevention Research |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Jul 23, 2021 |
| Last Updated Date: | Jul 23, 2021 |
| Original Closing Date for Applications: | – |
| Current Closing Date for Applications: | Sep 07, 2024 |
| Archive Date: | Oct 13, 2024 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | $500,000 |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Public housing authorities/Indian housing authorities City or township governments State governments Public and State controlled institutions of higher education Small businesses Private institutions of higher education Native American tribal organizations (other than Federally recognized tribal governments) Special district governments Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education County governments Independent school districts Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Others (see text field entitled “Additional Information on Eligibility” for clarification) For profit organizations other than small businesses Native American tribal governments (Federally recognized) |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | Through this funding opportunity announcement (FOA), the National Cancer Institute (NCI) seeks research project (R01) grant applications describing projects that integrate imaging and fluid-based tumor monitoring (liquid biopsy) assays during cancer therapy in patients to determine the optimal use of those modalities in the characterization of therapy response and/or emergence of resistance. |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/pa-files/PAR-21-290.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
grantsinfo@nih.gov Email:grantsinfo@nih.gov |
Related Documents
Folder 334872 Full Announcement-PAR-21-290 -> PAR-21-290-Full-Announcement.pdf
Packages
| Agency Contact Information: | NIH OER Webmaster grantsinfo@nih.gov Email: grantsinfo@nih.gov |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-G | Use for due dates on or before January 24, 2023 | PKG00269833 | Oct 28, 2021 | Jan 24, 2023 | View | |
| FORMS-F | Use for due dates on or before January 24, 2022 | PKG00268289 | Sep 05, 2021 | Jan 24, 2022 | View | |
| FORMS-H | Use for due dates on or before January 24, 2025 | PKG00277770 | Nov 01, 2022 | Jan 24, 2025 | View |
Package 1
Mandatory forms
334872 RR_SF424_5_0-5.0.pdf
334872 PHS398_CoverPageSupplement_5_0-5.0.pdf
334872 RR_OtherProjectInfo_1_4-1.4.pdf
334872 PerformanceSite_4_0-4.0.pdf
334872 RR_KeyPersonExpanded_4_0-4.0.pdf
334872 PHS398_ResearchPlan_4_0-4.0.pdf
334872 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
334872 RR_Budget_3_0-3.0.pdf
334872 RR_SubawardBudget30_3_0-3.0.pdf
334872 PHS398_ModularBudget_1_2-1.2.pdf
334872 PHS_AssignmentRequestForm_3_0-3.0.pdf
Package 2
Mandatory forms
334872 RR_SF424_2_0-2.0.pdf
334872 PHS398_CoverPageSupplement_5_0-5.0.pdf
334872 RR_OtherProjectInfo_1_4-1.4.pdf
334872 PerformanceSite_2_0-2.0.pdf
334872 RR_KeyPersonExpanded_2_0-2.0.pdf
334872 PHS398_ResearchPlan_4_0-4.0.pdf
334872 PHSHumanSubjectsAndClinicalTrialsInfo_2_0-2.0.pdf
Optional forms
334872 RR_Budget_1_4-1.4.pdf
334872 RR_SubawardBudget30_1_4-1.4.pdf
334872 PHS398_ModularBudget_1_2-1.2.pdf
334872 PHS_AssignmentRequestForm_3_0-3.0.pdf
Package 3
Mandatory forms
334872 RR_SF424_5_0-5.0.pdf
334872 PHS398_CoverPageSupplement_5_0-5.0.pdf
334872 RR_OtherProjectInfo_1_4-1.4.pdf
334872 PerformanceSite_4_0-4.0.pdf
334872 RR_KeyPersonExpanded_4_0-4.0.pdf
334872 PHS398_ResearchPlan_5_0-5.0.pdf
334872 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
334872 RR_Budget_3_0-3.0.pdf
334872 RR_SubawardBudget30_3_0-3.0.pdf
334872 PHS398_ModularBudget_1_2-1.2.pdf
334872 PHS_AssignmentRequestForm_3_0-3.0.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
